CNBC’s Jim Cramer on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will change food stocks.
You are here: Home / Jim Cramer says it’s too soon to tell how GLP-1 weight loss drugs will affect food stocks
Market News and Views
CNBC’s Jim Cramer on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will change food stocks.